Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Shelley Wood

September 14, 2018

News Conference News ESC 2018

FFRCT Shifts Patient Management, Linked to Better 90-Day Outcomes: ADVANCE Registry

Caitlin E. Cox

September 07, 2018

News Conference News ESC 2018

Oral Antibiotics for Endocarditis Allow for Safe, Early Hospital Discharge

L.A. McKeown

September 04, 2018

News Conference News ESC 2018

ASCOT Legacy: Calcium Channel Blockers, Statins Confer Long-term Survival Benefits in Hypertensive Patients

L.A. McKeown

August 31, 2018

News Conference News ESC 2018

SCOT-HEART: A Win for CT Angiography in Chest Pain Workup Prompts Cacophony of Reactions

Shelley Wood

August 31, 2018

Presentation ESC 2018

Association of dietary quality and risk of cardiovascular disease and mortality in 218,000 people from over 50 countries

Presenter: Andrew Mente

August 30, 2018

News Conference News ESC 2018

High-STEACS: Sensitive Troponin Tests Rule Out MI, but Have No Impact on Hard Events

Shelley Wood

August 29, 2018

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Conference News ESC 2018

VERDICT: Very Early Invasive Angiography No Help Overall for NSTE ACS

Todd Neale

August 29, 2018

News Conference News ESC 2018

Pretreatment With P2Y12 Inhibitors Questioned Anew in SCAAR

Shelley Wood

August 28, 2018

News Conference News ESC 2018

Redefined ‘High-Quality’ Diet Lowers Risk of All-Cause Mortality: PURE

Michael O'Riordan

August 28, 2018

News Conference News ESC 2018

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

Michael O'Riordan

August 28, 2018

ASCEND A randomized trial of omega-3 fatty acids (fish oil) versus placebo

Presentation ESC 2018

ASCEND A Randomized Trial of Omega-3 Fatty Acids (fish oil) vs Placebo

Presenter: Jane Armitage

August 27, 2018

Presentation ESC 2018

ASCEND Randomized placebo-controlled trial of aspirin

Presenter: Jane Armitage

August 27, 2018

Medically Ill Pa+ent Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results

Presentation ESC 2018

Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results

Presenter: Alex C. Spyropoulos

August 27, 2018

News Conference News ESC 2018

Tafamidis, a Transthyretin Stabilizer, Offers Hope for Rare Cardiomyopathy

Michael O'Riordan

August 27, 2018

News Conference News ESC 2018

COMMANDER HF: Low-Dose Rivaroxaban Flops in Heart Failure

Todd Neale

August 27, 2018

News Conference News ESC 2018

GLOBAL LEADERS: Ticagrelor Monotherapy Fails to Beat Conventional DAPT After PCI

Michael O'Riordan

August 27, 2018

News Conference News ESC 2018

MITRA-FR: No Benefit of MitraClip in Functional MR

Shelley Wood

August 27, 2018

News Conference News ESC 2018

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Michael O'Riordan

August 26, 2018

Advertisement

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

FFRCT Shifts Patient Management, Linked to Better 90-Day Outcomes: ADVANCE Registry

Oral Antibiotics for Endocarditis Allow for Safe, Early Hospital Discharge

ASCOT Legacy: Calcium Channel Blockers, Statins Confer Long-term Survival Benefits in Hypertensive Patients

SCOT-HEART: A Win for CT Angiography in Chest Pain Workup Prompts Cacophony of Reactions

Association of dietary quality and risk of cardiovascular disease and mortality in 218,000 people from over 50 countries

High-STEACS: Sensitive Troponin Tests Rule Out MI, but Have No Impact on Hard Events

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

VERDICT: Very Early Invasive Angiography No Help Overall for NSTE ACS

Pretreatment With P2Y12 Inhibitors Questioned Anew in SCAAR

Redefined ‘High-Quality’ Diet Lowers Risk of All-Cause Mortality: PURE

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

ASCEND A Randomized Trial of Omega-3 Fatty Acids (fish oil) vs Placebo

ASCEND Randomized placebo-controlled trial of aspirin

Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results

Tafamidis, a Transthyretin Stabilizer, Offers Hope for Rare Cardiomyopathy

COMMANDER HF: Low-Dose Rivaroxaban Flops in Heart Failure

GLOBAL LEADERS: Ticagrelor Monotherapy Fails to Beat Conventional DAPT After PCI

MITRA-FR: No Benefit of MitraClip in Functional MR

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content